Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 2
Submit an article Journal homepage
6,547
Views
84
CrossRef citations to date
0
Altmetric
Review

Trial Watch—Oncolytic viruses and cancer therapy

Jonathan PolINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, France
,
Aitziber BuquéINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, France
,
Fernando ArandaGroup of Immune receptors of the Innate and Adaptive System, Institut d’Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
,
Norma BloyINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, France
,
Isabelle CremerINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 13, Center de Recherche des Cordeliers, Paris, France
,
Alexander EggermontGustave Roussy Cancer Campus, Villejuif, France
,
Philippe ErbsTransgene S.A., Illkirch-Graffenstaden, France
,
Jitka FucikovaSotio, Prague, Czech Republic;Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic
,
Jérôme GalonINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France
,
Jean-Marc LimacherTransgene S.A., Illkirch-Graffenstaden, France
,
Xavier PrevilleTransgene S.A., Illkirch-Graffenstaden, France
,
Catherine Sautès-FridmanINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 13, Center de Recherche des Cordeliers, Paris, France
,
Radek SpisekSotio, Prague, Czech Republic;Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic
,
Laurence ZitvogelGustave Roussy Cancer Campus, Villejuif, France;INSERM, U1015, CICBT507, Villejuif, France
,
Guido KroemerINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, SwedenCorrespondence[email protected] [email protected]
&
Lorenzo GalluzziINSERM, U1138, Paris, France;Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Center de Recherche des Cordeliers, Paris, France;Gustave Roussy Cancer Campus, Villejuif, FranceCorrespondence[email protected] [email protected]
 show all
Article: e1117740 | Received 03 Nov 2015, Accepted 03 Nov 2015, Published online: 26 Feb 2016

Citations (84)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (17)

Boyang Yuan, Guoqing Wang, Xin Tang, Aiping Tong & Liangxue Zhou. (2022) Immunotherapy of glioblastoma: Recent advances and future prospects. Human Vaccines & Immunotherapeutics 18:5.
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Mihaela Angelova, Céline Mascaux & Jérôme Galon. (2021) Evasion before invasion: Pre-cancer immunosurveillance. OncoImmunology 10:1.
Read now
Pauline Maby, Gabriela Bindea, Bernhard Mlecnik & Jérôme Galon. (2021) License to kill: microsatellite instability and immune contexture. OncoImmunology 10:1.
Read now
Chin Liang Lee, Sanggeetha Veeramani, Aidin Molouki, Swee Hua Erin Lim, Warren Thomas, Suet Lin Chia & Khatijah Yusoff. (2019) Virotherapy: Current Trends and Future Prospects for Treatment of Colon and Rectal Malignancies. Cancer Investigation 37:8, pages 393-414.
Read now
Maria Eugenia Davola & Karen Louise Mossman. (2019) Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?. OncoImmunology 8:6.
Read now
Zhiwu Tan, Li Liu, Mei Sum Chiu, Ka-Wai Cheung, Chi Wing Yan, Zhe Yu, Boon Kiat Lee, Wan Liu, Kwan Man & Zhiwei Chen. (2019) Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression. OncoImmunology 8:1.
Read now
Jonathan G. Pol, Sergio A. Acuna, Beta Yadollahi, Nan Tang, Kyle B. Stephenson, Matthew J. Atherton, David Hanwell, Alexander El-Warrak, Alyssa Goldstein, Badru Moloo, Patricia V. Turner, Roberto Lopez, Sandra LaFrance, Carole Evelegh, Galina Denisova, Robin Parsons, Jamie Millar, Gautier Stoll, Chantal G. Martin, Julia Pomoransky, Caroline J. Breitbach, Jonathan L. Bramson, John C. Bell, Yonghong Wan, David F. Stojdl, Brian D. Lichty & J. Andrea McCart. (2019) Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials. OncoImmunology 8:1.
Read now
Jonathan G Pol, Matthew J Atherton, Byram W Bridle, Kyle B Stephenson, Fabrice Le Boeuf, Jeff L Hummel, Chantal G Martin, Julia Pomoransky, Caroline J Breitbach, Jean-Simon Diallo, David F Stojdl, John C Bell, Yonghong Wan & Brian D Lichty. (2018) Development and applications of oncolytic Maraba virus vaccines. Oncolytic Virotherapy 7, pages 117-128.
Read now
Adrian Pelin, Jiahu Wang, John Bell & Fabrice Le Boeuf. (2018) The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses. Oncolytic Virotherapy 7, pages 25-35.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now
Shashi Gujar, Jonathan G. Pol & Guido Kroemer. (2018) Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies. OncoImmunology 7:8.
Read now
Stefano Pierini, Renzo Perales-Linares, Mireia Uribe-Herranz, Jonathan G. Pol, Laurence Zitvogel, Guido Kroemer, Andrea Facciabene & Lorenzo Galluzzi. (2017) Trial watch: DNA-based vaccines for oncological indications. OncoImmunology 6:12.
Read now
Lorenzo Galluzzi & Peter Martin. (2017) CARs on a highway with roadblocks. OncoImmunology 6:12.
Read now
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now
Claire Vanpouille-Box, Claire Lhuillier, Lucillia Bezu, Fernando Aranda, Takahiro Yamazaki, Oliver Kepp, Jitka Fucikova, Radek Spisek, Sandra Demaria, Silvia C. Formenti, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2017) Trial watch: Immune checkpoint blockers for cancer therapy. OncoImmunology 6:11.
Read now
Rūta Veinalde, Christian Grossardt, Laura Hartmann, Marie-Claude Bourgeois-Daigneault, John C. Bell, Dirk Jäger, Christof von Kalle, Guy Ungerechts & Christine E. Engeland. (2017) Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation. OncoImmunology 6:4.
Read now

Articles from other publishers (67)

Xueqin Chen, Jun Liu, Yuqin Li, Yuequan Zeng, Fang Wang, Zexiong Cheng, Hao Duan, Guopeng Pan, Shangqi Yang, Yuling Chen, Qing Li, Xi Shen, Ying Li, Zixi Qin, Jiahong Chen, Youwei Huang, Xiangyu Wang, Yuli Lu, Minfeng Shu, Yubo Zhang, Guocai Wang, Kai Li, Xi Lin, Fan Xing & Haipeng Zhang. (2023) IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma. Nature Communications 14:1.
Crossref
Jia Tan, Meifang Wang, Binbin Ding, Ping'an Ma & Jun Lin. (2023) Advanced nanomaterials targeting activation of STING for enhanced cancer immunotherapy. Coordination Chemistry Reviews 493, pages 215316.
Crossref
Joseph Willis, Robert A. Anders, Toshihiko Torigoe, Yoshihiko Hirohashi, Carlo Bifulco, Inti Zlobec, Bernhard Mlecnik, Sandra Demaria, Won-Tak Choi, Pavel Dundr, Fabiana Tatangelo, Annabella Di Mauro, Pamela Baldin, Gabriela Bindea, Florence Marliot, Nacilla Haicheur, Tessa Fredriksen, Amos Kirilovsky, Bénédicte Buttard, Angela Vasaturo, Lucie Lafontaine, Pauline Maby, Carine El Sissy, Assia Hijazi, Amine Majdi, Christine Lagorce, Anne Berger, Marc Van den Eynde, Franck Pagès, Alessandro Lugli & Jérôme Galon. (2023) Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore. Cancers 15:16, pages 4045.
Crossref
Mohammad Javanbakht, Sanaz Tahmasebzadeh, Luca Cegolon, Nasrin Gholami, Mandana Kashaki, Hassan Nikoueinejad, Mohamad Mozafari, Mahsa Mozaffari, Shi Zhao, Mostafa Khafaei, Morteza Izadi, Saeid Fathi & Reza Akhavan-Sigari. (2023) Oncolytic viruses: A novel treatment strategy for breast cancer. Genes & Diseases 10:2, pages 430-446.
Crossref
Juliette Humeau, Julie Le Naour, Guido Kroemer & Jonathan G. Pol. 2023.
Osman Yılmaz, Amaya Pankaj, Azfar Neyez, Steffen Rickelt, Martin Taylor, Evan R. Lang, Lieve Leijsen, Anne Dinaux, Stuti G. Shroff, Rory Crotty, M. Lisa Zhang, Sandra Cerda, Qing Zhao, Cristina Ferrone, David T. Ting, Deepa T. Patil, Omer Yilmaz, David Berger & Vikram Deshpande. (2022) Programmed death-ligand 1 expression in the immune compartment of colon carcinoma. Modern Pathology 35:11, pages 1740-1748.
Crossref
Yinghan Su, Changqing Su & Lunxiu Qin. (2022) Current landscape and perspective of oncolytic viruses and their combination therapies. Translational Oncology 25, pages 101530.
Crossref
Veronique Beiss, Chenkai Mao, Steven N. Fiering & Nicole F. Steinmetz. (2022) Cowpea Mosaic Virus Outperforms Other Members of the Secoviridae as In Situ Vaccine for Cancer Immunotherapy. Molecular Pharmaceutics 19:5, pages 1573-1585.
Crossref
Yogesh R. Suryawanshi, Rebecca A. Nace, Stephen J. Russell & Autumn J. Schulze. (2021) MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model. Molecular Therapy - Oncolytics 23, pages 1-13.
Crossref
Yu-Chao Zhu, Hany M Elsheikha, Jian-Hua Wang, Shuai Fang, Jun-Jun He, Xing-Quan Zhu & Jia Chen. (2021) Synergy between Toxoplasma gondii type I Δ GRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors . Journal for ImmunoTherapy of Cancer 9:11, pages e002970.
Crossref
Mina Shahnazari, Pouria Samadi, Mona Pourjafar & Akram Jalali. (2021) Cell-based immunotherapy approaches for colorectal cancer: main achievements and challenges. Future Oncology 17:24, pages 3253-3270.
Crossref
Joshua Del Papa, Ryan G. Clarkin & Robin J. Parks. (2020) Use of cell fusion proteins to enhance adenoviral vector efficacy as an anti-cancer therapeutic. Cancer Gene Therapy 28:7-8, pages 745-756.
Crossref
Yogesh R. Suryawanshi & Autumn J. Schulze. (2021) Oncolytic Viruses for Malignant Glioma: On the Verge of Success?. Viruses 13:7, pages 1294.
Crossref
Jitka Fucikova, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Calreticulin and cancer. Cell Research 31:1, pages 5-16.
Crossref
Jerome H. Hochman. (2021) Adapting ADME and Pharmacokinetic Analysis to the Next Generation of Therapeutic Modalities. Journal of Pharmaceutical Sciences 110:1, pages 35-41.
Crossref
Bin Zheng, Yanan Xu, Mengqian Huang, Xianhuang Li, Tao Wang & Dong Ming. (2020) Bio-Inorganic Hybrid Nongenetically Modified Viruses as an Immune Agonist for Systemic Elimination of Cancer Cells. ACS Applied Materials & Interfaces 12:48, pages 53691-53704.
Crossref
Jérémy Béguin, Johann Foloppe, Christelle Maurey, Eve Laloy, Julie Hortelano, Virginie Nourtier, Christelle Pichon, Sandrine Cochin, Pascale Cordier, Hélène Huet, Eric Quemeneur, Bernard Klonjkowski & Philippe Erbs. (2020) Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer. Molecular Therapy - Oncolytics 19, pages 57-66.
Crossref
Jonathan G. Pol, Samuel T. Workenhe, Prathyusha Konda, Shashi Gujar & Guido Kroemer. (2020) Cytokines in oncolytic virotherapy. Cytokine & Growth Factor Reviews 56, pages 4-27.
Crossref
Vera Kemp, Martine L.M. Lamfers, Gabri van der Pluijm, Bernadette G. van den Hoogen & Rob C. Hoeben. (2020) Developing oncolytic viruses for clinical use: A consortium approach. Cytokine & Growth Factor Reviews 56, pages 133-140.
Crossref
J. Zhang, Q. Zhang, X. Chen & N. Zhang. (2019) Management of neoplastic pericardial diseaseBehandlung neoplastisch bedingter Erkrankungen des Perikards. Herz 45:S1, pages 46-51.
Crossref
Laura Menotti & Elisa Avitabile. (2020) Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy. International Journal of Molecular Sciences 21:21, pages 8310.
Crossref
Feng-Ying Huang, Jin-Yan Wang, Shu-Zhen Dai, Ying-Ying Lin, Yan Sun, Liming Zhang, Zhuoxuan Lu, Rong Cao & Guang-Hong Tan. (2020) A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity. Journal for ImmunoTherapy of Cancer 8:2, pages e000330.
Crossref
Esther N. Arwert, Emma L. Milford, Antonio Rullan, Stefanie Derzsi, Steven Hooper, Takuya Kato, David Mansfield, Alan Melcher, Kevin J. Harrington & Erik Sahai. (2020) STING and IRF3 in stromal fibroblasts enable sensing of genomic stress in cancer cells to undermine oncolytic viral therapy. Nature Cell Biology 22:7, pages 758-766.
Crossref
Nicolas Mach, Jian Gao, Lukas Schaffarczyk, Sebastian Janz, Eric Ehrke-Schulz, Thomas Dittmar, Anja Ehrhardt & Wenli Zhang. (2020) Spectrum-Wide Exploration of Human Adenoviruses for Breast Cancer Therapy. Cancers 12:6, pages 1403.
Crossref
Shahin Shams & Eduardo A. Silva. 2020. Engineering Strategies for Regenerative Medicine. Engineering Strategies for Regenerative Medicine 107 148 .
Johannes P. W. Heidbuechel, Daniel Abate-Daga, Christine E. Engeland & Heiko Enderling. 2020. Oncolytic Viruses. Oncolytic Viruses 307 320 .
Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K. Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T. Hirvonen, Hélder A. Santos & Vincenzo Cerullo. (2019) Artificially cloaked viral nanovaccine for cancer immunotherapy. Nature Communications 10:1.
Crossref
Alberto Reale, Adriana Vitiello, Valeria Conciatori, Cristina Parolin, Arianna Calistri & Giorgio Palù. (2019) Perspectives on immunotherapy via oncolytic viruses. Infectious Agents and Cancer 14:1.
Crossref
Masaya Igase, Shusaku Shibutani, Yosuke Kurogouchi, Noriyuki Fujiki, Chung Chew Hwang, Matt Coffey, Shunsuke Noguchi, Yuki Nemoto & Takuya Mizuno. (2019) Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma. Molecular Therapy - Oncolytics 15, pages 49-59.
Crossref
Jian Gao, Kemal Mese, Oskar Bunz & Anja Ehrhardt. (2019) State‐of‐the‐art human adenovirus vectorology for therapeutic approaches. FEBS Letters 593:24, pages 3609-3622.
Crossref
Li-Li Huang, Xue Li, JinFeng Zhang, Qian Ru Zhao, Ming Jing Zhang, An-An Liu, Dai-Wen Pang & Hai-Yan Xie. (2019) MnCaCs-Biomineralized Oncolytic Virus for Bimodal Imaging-Guided and Synergistically Enhanced Anticancer Therapy. Nano Letters 19:11, pages 8002-8009.
Crossref
Kevin Harrington, Daniel J. Freeman, Beth Kelly, James Harper & Jean-Charles Soria. (2019) Optimizing oncolytic virotherapy in cancer treatment. Nature Reviews Drug Discovery 18:9, pages 689-706.
Crossref
Stefanie Maurer, Helmut Salih, Irina Smirnow, Ulrich Lauer & Susanne Berchtold. (2019) Suicide gene‑armed measles vaccine virus for the treatment of AML. International Journal of Oncology.
Crossref
Xiaoyan Shao, Xueke Wang, Xianling Guo, Ke Jiang, Tian Ye, Jianhua Chen, Juemin Fang, Linaer Gu, Sitong Wang, Guirong Zhang, Songshu Meng & Qing Xu. (2019) STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells. Frontiers in Oncology 9.
Crossref
Peng Lv, Xuan Liu, Xiaomei Chen, Chao Liu, Yang Zhang, Chengchao Chu, Junqing Wang, Xiaoyong Wang, Xiaoyuan Chen & Gang Liu. (2019) Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy. Nano Letters 19:5, pages 2993-3001.
Crossref
Margarita GarcíaRafael MorenoMarta Gil-MartinManel CascallòMaria Ochoa de OlzaCarmen CuadraJosep Maria PiulatsValentin NavarroMarta DomenechRamon AlemanyRamon Salazar. (2019) A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients. Human Gene Therapy 30:3, pages 352-364.
Crossref
Eva LichteneggerFlorestan KollHelena HaasKlaus MantwillKlaus-Peter JanssenMelanie LaschingerJürgen GschwendKatja SteigerPeter C. BlackIgor MoskalevRoman NawrothPer Sonne Holm. (2019) The Oncolytic Adenovirus XVir-N-31 as a Novel Therapy in Muscle-Invasive Bladder Cancer. Human Gene Therapy 30:1, pages 44-56.
Crossref
Adam Ajina & John Maher. 2019. Cancer Immunotherapy. Cancer Immunotherapy 217 292 .
Juliette Humeau, Sarah Lévesque, Guido Kroemer & Jonathan G. Pol. 2019. Cancer Immunosurveillance. Cancer Immunosurveillance 297 315 .
Neil S. Forbes, Robert S. Coffin, Liang Deng, Laura Evgin, Steve Fiering, Matthew Giacalone, Claudia Gravekamp, James L. Gulley, Hal Gunn, Robert M. Hoffman, Balveen Kaur, Ke Liu, Herbert Kim Lyerly, Ariel E. Marciscano, Eddie Moradian, Sheryl Ruppel, Daniel A. Saltzman, Peter J. Tattersall, Steve Thorne, Richard G. Vile, Halle Huihong Zhang, Shibin Zhou & Grant McFadden. (2018) White paper on microbial anti-cancer therapy and prevention. Journal for ImmunoTherapy of Cancer 6:1.
Crossref
Amanda L. Huff, Phonphimon Wongthida, Timothy Kottke, Jill M. Thompson, Christopher B. Driscoll, Matthew Schuelke, Kevin G. Shim, Reuben S. Harris, Amy Molan, Jose S. Pulido, Peter J. Selby, Kevin J. Harrington, Alan Melcher, Laura Evgin & Richard G. Vile. (2018) APOBEC3 Mediates Resistance to Oncolytic Viral Therapy. Molecular Therapy - Oncolytics 11, pages 1-13.
Crossref
Tereza Brachtlova & Victor van Beusechem. (2018) Unleashing the Full Potential of Oncolytic Adenoviruses against Cancer by Applying RNA Interference: The Force Awakens. Cells 7:12, pages 228.
Crossref
Chrisann Kyi, Vladimir Roudko, Rachel Sabado, Yvonne Saenger, William Loging, John Mandeli, Tin Htwe Thin, Deborah Lehrer, Michael Donovan, Marshall Posner, Krzysztof Misiukiewicz, Benjamin Greenbaum, Andres Salazar, Philip Friedlander & Nina Bhardwaj. (2018) Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial. Clinical Cancer Research 24:20, pages 4937-4948.
Crossref
Pēteris Alberts, Andra Tilgase, Agnija Rasa, Katrīna Bandere & Dite Venskus. (2018) The advent of oncolytic virotherapy in oncology: The Rigvir® story. European Journal of Pharmacology 837, pages 117-126.
Crossref
Carles Urbiola, Frédéric R. Santer, Monika Petersson, Gabri van der Pluijm, Wolfgang Horninger, Patrik Erlmann, Guido Wollmann, Janine Kimpel, Zoran Culig & Dorothee von Laer. (2018) Oncolytic activity of the rhabdovirus VSV‐GP against prostate cancer. International Journal of Cancer 143:7, pages 1786-1796.
Crossref
Margarita GarciaRafael MorenoMarta GilManel CascalloMaria Ochoa de OlzaCarmen CuadraJosep Maria PiulatValentin NavarroMarta DomenechRamon AlemanyRamon Salazar. (2018) A phase I trial of oncolytic adenovirus ICOVIR-5 administered intravenously to melanoma patients. Human Gene Therapy Clinical Development.
Crossref
Gayathri Kandasamy, Vadim Annenkov & Uma Maheswari Krishnan. (2018) Nanoimmunotherapy – cloaked defenders to breach the cancer fortress. Nanotechnology Reviews 7:4, pages 317-340.
Crossref
Hiroshi Nakashima, Tran Nguyen, Kazue Kasai, Carmela Passaro, Hirotaka Ito, William F. Goins, Imran Shaikh, Ronald Erdelyi, Reiko Nishihara, Ichiro Nakano, David A. Reardon, Ana C. Anderson, Vijay Kuchroo & E. Antonio Chiocca. (2018) Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma. Clinical Cancer Research 24:11, pages 2574-2584.
Crossref
Mathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, Luisa Henkel, Hans Martin Singh, Sascha Bossow, Christine E. Engeland, Russell Barkley, Birgit Hoyler, Jessica Albert, Christoph Springfeld, Dirk Jäger, Christof von Kalle & Guy Ungerechts. (2018) Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites. Molecular Therapy - Oncolytics 9, pages 30-40.
Crossref
Tobias Speck, Johannes P.W. Heidbuechel, Rūta Veinalde, Dirk Jaeger, Christof von Kalle, Claudia R. Ball, Guy Ungerechts & Christine E. Engeland. (2018) Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors. Clinical Cancer Research 24:9, pages 2128-2137.
Crossref
Patrick Lee & Shashi Gujar. (2018) Potentiating prostate cancer immunotherapy with oncolytic viruses. Nature Reviews Urology 15:4, pages 235-250.
Crossref
Biljana Petrovic, Valerio Leoni, Valentina Gatta, Anna Zaghini, Andrea Vannini & Gabriella Campadelli-Fiume. (2018) Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells. Journal of Virology 92:6.
Crossref
Mitchell E. Menezes, Sarmistha Talukdar, Stephen L. Wechman, Swadesh K. Das, Luni Emdad, Devanand Sarkar & Paul B. Fisher. 2018. 213 237 .
Daniel E. Meyers, Satbir Thakur, Chandini M. Thirukkumaran & Don G. Morris. (2017) Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma. Blood Cancer Journal 7:12.
Crossref
Marine Ricordel, Johann Foloppe, Christelle Pichon, Nathalie Sfrontato, Delphine Antoine, Caroline Tosch, Sandrine Cochin, Pascale Cordier, Eric Quemeneur, Christelle Camus-Bouclainville, Stéphane Bertagnoli & Philippe Erbs. (2017) Cowpox Virus: A New and Armed Oncolytic Poxvirus. Molecular Therapy - Oncolytics 7, pages 1-11.
Crossref
Nikéa Pittman, Adam Misseldine, Lorena Geilen, Sujata Halder, J. Smith, Justin Kurian, Paul Chipman, Mandy Janssen, Robert Mckenna, Timothy Baker, Anthony D’Abramo Jr.Susan Cotmore, Peter Tattersall & Mavis Agbandje-McKenna. (2017) Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction. Viruses 9:11, pages 321.
Crossref
Lisa Wall & Abigail Baldwin-Medsker. (2017) Safe and Effective Standards of Care: Supporting the Administration of T-VEC for Patients With Advanced Melanoma in the Outpatient Oncology Setting
. Clinical Journal of Oncology Nursing 21:5, pages E260-E266.
Crossref
Guy UngerechtsChristine E. EngelandChristian J. BuchholzJürgen EberleHenry FechnerKarsten GeletnekyPer Sonne HolmFlorian KreppelFlorian KühnelKarl Sebastian LangMathias F. LeberAntonio MarchiniMarkus MoehlerMichael D. MühlebachJean RommelaereChristoph SpringfeldUlrich M. LauerDirk M. Nettelbeck. (2017) Virotherapy Research in Germany: From Engineering to Translation. Human Gene Therapy 28:10, pages 800-819.
Crossref
Fabrice Le Boeuf, Simon Gebremeskel, Nichole McMullen, Han He, Anna L. Greenshields, David W. Hoskin, John C. Bell, Brent Johnston, Chungen Pan & Roy Duncan. (2017) Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models. Molecular Therapy - Oncolytics 6, pages 80-89.
Crossref
Laetitia Fend, Takahiro Yamazaki, Christelle Remy, Catherine Fahrner, Murielle Gantzer, Virginie Nourtier, Xavier Préville, Eric Quéméneur, Oliver Kepp, Julien Adam, Aurélien Marabelle, Jonathan M. Pitt, Guido Kroemer & Laurence Zitvogel. (2017) Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. Cancer Research 77:15, pages 4146-4157.
Crossref
Dörthe Masemann, Yvonne Boergeling & Stephan Ludwig. (2017) Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy. Biological Chemistry 398:8, pages 891-909.
Crossref
Daniel E. Meyers, Amanda A. Wang, Chandini M. Thirukkumaran & Don G. Morris. (2017) Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy. Frontiers in Oncology 7.
Crossref
Nalini Marino, Sam Illingworth, Prithvi Kodialbail, Ashvin Patel, Hugo Calderon, Rochelle Lear, Kerry D. Fisher, Brian R. Champion & Alice C. N. Brown. (2017) Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes. PLOS ONE 12:5, pages e0177810.
Crossref
Qi-Xiang Li, Gerold Feuer, Xuesong Ouyang & Xiaoyu An. (2017) Experimental animal modeling for immuno-oncology. Pharmacology & Therapeutics 173, pages 34-46.
Crossref
Justin Maroun, Miguel Muñoz-Alía, Arun Ammayappan, Autumn Schulze, Kah-Whye Peng & Stephen Russell. (2017) Designing and building oncolytic viruses. Future Virology 12:4, pages 193-213.
Crossref
Olga Koval, Galina Kochneva, Anastasiya Tkachenko, Olga Troitskaya, Galina Sivolobova, Antonina Grazhdantseva, Anna Nushtaeva, Elena Kuligina & Vladimir Richter. (2017) Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells. BioMed Research International 2017, pages 1-14.
Crossref
Amanda Rosewell Shaw & Masataka Suzuki. (2016) Recent advances in oncolytic adenovirus therapies for cancer. Current Opinion in Virology 21, pages 9-15.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.